INS and metabolic syndrome: However, Bouter et al. (2018) found that sodium butyrate supplementation for 1 month did not affect hepatic or peripheral insulin sensitivity in metabolic syndrome subjects that were sufficient in fecal SCFA, but improved insulin sensitivity in healthy lean subjects that were also sufficient in fecal SCFA.